Figure 10.

Application of the proposed simulation pipeline on a clinical example. The inital vulnerability map (A) shows numerous pathways along which AFlut can be sustained. By closing the gap in the previous line on the left part of the anterior wall (green arrow), the number of pathways could be reduced but a significant amount remained (B). The extrapolated phase map (C) for one of the pathways identified in (B) (gray line in D) was used to intialize a dynamic fast marching simulation (D) exhibiting stable reentry. Additional ablation to the (RSPV) (green arrow) eliminated all vulnerable pathways (E).